The Cutting Edge of Medical Technology Content, Community & Collaboration
Highlights of OnBioVC (Venture Capital) September 2009 BioScience Summary Report
Colleagues,
The always useful OnBioVC report has been published for September 2009 ... Here are the highlights ...
... 27 bioscience financings for September ‘09 versus 25 deals in September ‘08. The ninth month of 2009 combined bioscience investment proceeds totaled approximately $465.5M, an decrease of roughly $109.3M compared to the $574.5M of investments tracked in the ninth month of ’08, yielding a month-over-month investment decrease of ~18.9%...
... The first nine month capital totals place 2009 at a run rate of $6,409M; if this value holds than a variance of approximately ($1,550M) would be expected relative to the 2008 tracked
total capital raise of $7,960M...
... The largest deal of September ‘09 went to the Seattle, WA based Calypso Medical with $50M in fifth round funding. The Company is focused on tumor localization system which utilizes miniaturized implanted devices (Beacon® electromagnetic transponders) to continuously, accurately and objectively track the location of tumors for improved accuracy and management of radiation therapy delivery...
... In Diagnostic focused entities ... five companies accounted for $71.7M, the largest financing, a $23M Series E, closed by Agendia based in the Netherlands, is focused on expression profiling and patient stratification in breast and colon cancers...
... California continued its dominance in attracting investment dollars. CA was home to 10 financings in September ‘09 accounting for $158.8M...
.. The Medical Device sector attracted $258.6M, and 14 deals. The Biopharma sector accounted for $110.2M across 7 deals...
Read on at: http://onbiovc.com/wp-content/uploads/2009/11/onbiovc-trend-analysi...
ENJOY!
CC
The always useful OnBioVC report has been published for September 2009 ... Here are the highlights ...
... 27 bioscience financings for September ‘09 versus 25 deals in September ‘08. The ninth month of 2009 combined bioscience investment proceeds totaled approximately $465.5M, an decrease of roughly $109.3M compared to the $574.5M of investments tracked in the ninth month of ’08, yielding a month-over-month investment decrease of ~18.9%...
... The first nine month capital totals place 2009 at a run rate of $6,409M; if this value holds than a variance of approximately ($1,550M) would be expected relative to the 2008 tracked
total capital raise of $7,960M...
... The largest deal of September ‘09 went to the Seattle, WA based Calypso Medical with $50M in fifth round funding. The Company is focused on tumor localization system which utilizes miniaturized implanted devices (Beacon® electromagnetic transponders) to continuously, accurately and objectively track the location of tumors for improved accuracy and management of radiation therapy delivery...
... In Diagnostic focused entities ... five companies accounted for $71.7M, the largest financing, a $23M Series E, closed by Agendia based in the Netherlands, is focused on expression profiling and patient stratification in breast and colon cancers...
... California continued its dominance in attracting investment dollars. CA was home to 10 financings in September ‘09 accounting for $158.8M...
.. The Medical Device sector attracted $258.6M, and 14 deals. The Biopharma sector accounted for $110.2M across 7 deals...
Read on at: http://onbiovc.com/wp-content/uploads/2009/11/onbiovc-trend-analysi...
ENJOY!
CC
Views: 10
MedTechIQ VideoLibrary
Upcoming Events
© 2024 Created by CC-Conrad Clyburn-MedForeSight.
Powered by
